References
- Grillner L, Bergdahl S, Jyrälä A. Non-A, non-B hepatitis after open-heart surgery in Sweden. Scand J Infect Dis 1982; 14: 171–5
- Olsson R, Hermodsson S, Roberts D., Waldenström J. Hepatic dysfunction after open-heart surgery. Scand J Thorac Cardio-vasc Surg 1984; 18: 217–22
- Widell A, Sundstrom G, Hansson B G, Fex G, Moestrup T, Nordenfelt E. Post-transfusion hepatitis non-A, non-B in southern Sweden: occurrence and clinical significance. Scand J Infect Dis 1987; 19: 603–10
- Mattsson L, Åberg B, Weiland O, Sellman M, Davil6n J. Non-A, non-B hepatitis after open-heart surgery in Stockholm: declining incidence after the introduction of restrictions for blood donations due to the human immunodeficiency virus. Scand J Infect Dis 1988; 20: 371–6
- Ebeling F, Naukkarinen R, Hanhela R, et al. Post-transfusion hepatitis after open-heart surgery in Finland–a prospective study. Transf Med 1991; 1: 103–8
- Contreras M, Barbara J AJ, Anderson C C, et al. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology. Lancet 1991; 337: 753–7
- Kuo G, Choo Q L, Alter H J, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–4
- Alter H. New kit on the block: evaluation of second generation assays for detection of antibody to the hepatitis C virus [editorial]. Hepatology 1992; 15: 350–3
- Widell A, Persson A S, Sundström G, Hansson B G, Nordenfelt E. Hepatitis C virus RNA in blood donor sera detected by polymerase chain reaction: comparison with supplementary hepatitis C antibody assays. J Med Virol 1991; 35: 253–8
- Aach R D, Szmuness W, Mosley J W, et al. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. N Engl J Med 1981; 304: 989–94
- Alter H J, Purcell R H, Holland P V, Ailing D W, Koziol D E. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA 1981; 246: 630–4
- Stevens C E, Aach R D, Hollinger F B, et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. Ann Intern Med 1984; 101: 733–8
- Koziol D, Holland P V, Ailing D W, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986; 104: 488–95
- Mathiesen U L, Ekermo B, Foberg U, et al. Anti-HCVscreening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas. Scand J Gastroenterol 1992; 27: 443–8
- Weiland O, Schwarcz R. Hepatitis C: virology, epidemiology, clinical course and treatment, [review]. Scand J Gastroenterol 1992; 27: 337–42
- McHutchison J G, Person J L, Govidarajan S, et al. Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology 1992; 15: 19–25
- Follett E AC, Dow B C, McOmish F, et al. HCV confirmatory testing of blood donors. Lancet 1991; 338: 1024